Makes a sense to wait and see when evidence is there? Anktiva from IBRX, question.

FDA approved.SFDA approved.EMA fast track approved. Phase 3 for lung cancer. Phase 1/2 for pancreatic cancer, lymphoma. All the behind the scenes tech involved,the supporting science ebidence and pathways,all the possible pipelines as combo treatment improving survival rates...this looks very very promising.